GENETICS OF SCLERODERMA

[1] Campbell, Trowsdale, Map of the human MHC, Immunology Today, 14, 7, pp. 349-352, (1993)

[2] Gammon, Fine, Forbes, Briggaman, Immunofluorescence on split skin for the detection and differentiation of basement membrane zone antibodies, J Am Acad Dermatol, 27, pp. 79-87, (1992)

[3] Black, Stephens, Systemic sclerosis (scleroderma) and related disorders, Oxford Textbook of Rheumatology, 2, pp. 771-789, (1993)

[4] Tramposch, Smith, Senecal, Et al., A long-term longitudinal study of anticentromere antibodies, Arthritis Rheum, 27, pp. 121-124, (1984)

[5] Fritzler, Kinsella, Garbutt, The CREST syndrome: A distinct serologic entity with anticentromere antibodies, Am J Med, 69, pp. 520-526, (1980)

[6] Brenner, Pepper, Berns, Tan, Brinkley, Kinetochore structure, duplication and distribution in mammalian cells: Analysis by human autoantibodies from scleroderma patients, J Cell Biol, 91, pp. 95-102, (1981)

[7] Earnshaw, Bordwell, Marino, Rothfield, Three human chromosomal autoantigens are recognized by sera from patients with anticentromere antibodies, J Clin Invest, 77, pp. 426-430, (1986)

[8] Douvas, Achten, Tan, Identification of a nuclear protein (Scl-70) as a unique target of human antinuclear antibodies in scleroderma, J Biol Chem, 254, pp. 10514-10522, (1979)

[9] Shero, Bordwell, Rothfield, Et al., High titers of autoantibodies to topoisomerase I (Scl-70) in sera from scleroderma patients, Science, 231, pp. 737-740, (1986)

[10] Maul, French, Van Venrooij, Et al., Topoisomerase I identified by scleroderma 70 antisera: Enrichment of topoisomerase I at the centromere in mouse mitotic cells before anaphase, Proc Natl Acad Sci USA, 83, pp. 5145-5149, (1986)

[1] Campbell, Trowsdale, Map of the human MHC, Immunology Today, 14, 7, pp. 349-352, (1993)

[2] Gammon, Fine, Forbes, Briggaman, Immunofluorescence on split skin for the detection and differentiation of basement membrane zone antibodies, J Am Acad Dermatol, 27, pp. 79-87, (1992)

[3] Black, Stephens, Systemic sclerosis (scleroderma) and related disorders, Oxford Textbook of Rheumatology, 2, pp. 771-789, (1993)

[4] Tramposch, Smith, Senecal, Et al., A long-term longitudinal study of anticentromere antibodies, Arthritis Rheum, 27, pp. 121-124, (1984)

[5] Fritzler, Kinsella, Garbutt, The CREST syndrome: A distinct serologic entity with anticentromere antibodies, Am J Med, 69, pp. 520-526, (1980)

[6] Brenner, Pepper, Berns, Tan, Brinkley, Kinetochore structure, duplication and distribution in mammalian cells: Analysis by human autoantibodies from scleroderma patients, J Cell Biol, 91, pp. 95-102, (1981)

[7] Earnshaw, Bordwell, Marino, Rothfield, Three human chromosomal autoantigens are recognized by sera from patients with anticentromere antibodies, J Clin Invest, 77, pp. 426-430, (1986)

[8] Douvas, Achten, Tan, Identification of a nuclear protein (Scl-70) as a unique target of human antinuclear antibodies in scleroderma, J Biol Chem, 254, pp. 10514-10522, (1979)

[9] Shero, Bordwell, Rothfield, Et al., High titers of autoantibodies to topoisomerase I (Scl-70) in sera from scleroderma patients, Science, 231, pp. 737-740, (1986)

[10] Maul, French, Van Venrooij, Et al., Topoisomerase I identified by scleroderma 70 antisera: Enrichment of topoisomerase I at the centromere in mouse mitotic cells before anaphase, Proc Natl Acad Sci USA, 83, pp. 5145-5149, (1986)